Menkes disease is a heartbreaking condition. Babies are born with it due to a faulty gene on the X chromosome.
This gene is supposed to help the body use copper. Copper is a crucial micronutrient. It’s essential for building a baby’s brain, nerves, bones, and blood vessels during pregnancy.
Without it working right, copper can’t get to where it’s needed. Babies with Menkes typically appear normal at birth but deteriorate within months. They experience severe developmental delays, weak muscle tone, and seizures. Life expectancy is tragically short.
Current treatment involves injecting copper directly into a vein. But it must start very early to have any chance of helping. Even then, results are limited. The search for ways to improve outcomes is desperate and ongoing.
The Old Thinking vs. The New Question
For a long time, Menkes was viewed purely as a genetic tragedy. The severity was thought to be locked in by the baby’s specific DNA mutation.
The focus was entirely on the child’s genes and how to treat the baby after birth.
But here’s the twist.
This new review asks us to look upstream—at the mother’s pregnancy. Specifically, at her nutritional environment. The researchers propose that an external, modifiable factor might influence the disease: too much zinc.
How Zinc and Copper Compete
To understand this, think of a busy single-lane bridge.
Copper and zinc are both essential minerals. But they use the same “bridge” to get absorbed in the gut and transferred through the placenta to the baby. They are competitors.
In a normal pregnancy, this system is balanced. The mother’s body prioritizes getting copper to her growing fetus, especially in the third trimester.
Now, imagine a baby who already has a broken-down truck (the genetic defect) trying to carry copper across that bridge. It’s a struggle.
The new hypothesis suggests that high levels of zinc from supplements act like a convoy of speeding cars. They flood the bridge. They make it even harder for the baby’s already-impaired system to grab what little copper it can.
This competitive antagonism could plunge the genetically vulnerable fetus into deeper copper deficiency before it’s even born.
A Snapshot of the Evidence
The researchers didn’t conduct a new trial. Instead, they meticulously reviewed existing science.
They pooled data from studies on pregnant women, animal research, and scattered medical case reports. A clear pattern emerged from this mosaic. High zinc intake consistently lowers copper levels in mothers and their fetuses.
The critical, unanswered question is: What does this zinc-induced copper drop do to a fetus that is genetically incapable of handling copper properly?
The Missing Piece for Menkes
The data shows the mechanism is plausible. Biology supports it. But no one has ever specifically studied it in the context of Menkes disease pregnancies.
That’s the glaring gap.
The researchers found no large-scale studies tracking zinc supplement use in mothers who later had a baby diagnosed with Menkes. They found no research comparing disease severity in babies whose mothers took high-dose zinc versus those who didn’t.
The connection is a compelling, but unproven, medical hypothesis.
This Is Where It Gets Personal
This isn't just an academic debate. Zinc supplementation skyrocketed during the COVID-19 pandemic for its immune support. It remains a wildly popular over-the-counter supplement.
Many prenatal vitamins also contain zinc. Women are often told it’s beneficial.
For a pregnant woman carrying a baby with the Menkes gene—which she would have no way of knowing—this common practice could be anything but beneficial.
It could be an environmental trigger that worsens her child’s prognosis.
An Expert Call for Caution and Clarity
The scientists behind this review are not saying zinc is bad. It is a vital nutrient.
They are sounding an alarm for a specific, rare scenario. They emphasize an urgent need for “targeted retrospective analyses and well-designed prospective studies.”
In plain language: We need to go back and look at the medical histories of Menkes patients. We need to start carefully tracking zinc use in future at-risk pregnancies. The goal is to move from a worrying “what if” to solid evidence.
What This Means for You Today
This does not mean you should stop taking your prenatal vitamins.
This is a hypothesis for a rare condition, not a warning for the general public.
If you are pregnant or planning to be, do not make sudden changes to your supplements based on this article. Always talk to your doctor about what you’re taking.
The immediate implication is for researchers and doctors specializing in genetic metabolic diseases. It asks them to add a simple question to their patient history: What supplements was the mother taking?
The Limitations Are Clear
The biggest limitation is the lack of direct evidence. This is a theory built on indirect data. We don’t know how many women this might affect, or to what degree zinc might change outcomes.
Menkes disease is also very rare, affecting about 1 in 100,000 newborns. This makes large studies difficult.
The path forward is one of urgent investigation. The researchers have laid out a clear roadmap.
First, retrospective studies must dig through old medical records. Then, prospective studies must monitor at-risk pregnancies moving forward. This will take time and global collaboration.
The ultimate hope is that this leads to a re-evaluation of prenatal micronutrient guidance for families with a known genetic risk. Something as simple as balancing zinc and copper intake could one day become a tool to give these vulnerable babies a better chance from their very first breath.
